Share on LinkedInShare on LinkedIn

ARTICLE · 09 DECEMBER 2012

Pharmaceutical brand owners beware – changes to medicine packaging ahead

Proposed changes will impact brand owners in the pharmaceutical industry, restricting IP in packaging and labelling.

AustraliaIntellectual Property

What does this mean for pharmaceutical brand owners?

In the coming year the TGA will aim to change the way pharmaceuticals can be labelled to restrict some brand extensions. There will be new obligations to clear trade marks for use on new products. There will also be prescribed harmonisation of the "look and feel" of packaging.

The Therapeutic Goods Administration

The Therapeutic Goods Administration (TGA) is the regulatory authority that regulates medicines supplied in Australia.

The TGA regulates prescription, OTC, and complementary medicines, medical devices and biological medical products such as blood products. The TGA regulates these goods through pre-market assessment, monitoring and enforcing standards, licensing Australian manufacturers and verifying compliance of overseas manufacturers.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from